GE CARESCAPE Central Station Recalled Over Patient Monitoring Delay 2026

Health Canada has issued a Type II medical device recall for the CARESCAPE Central Station, a hospital patient-monitoring system manufactured by Ge Medical Systems Information Technologies Inc., a division of GE Healthcare. The recall, dated 2026-08-14 and published on 2026-08-26 under identification number RA-82531, affects units running software version 3.0.x that are used in Canadian healthcare facilities to track patients’ vital signs from a central nursing station.

According to Health Canada, GE Healthcare identified a flaw in which the CARESCAPE Central Station (CSCS) v3.0.x ‘may not resume patient monitoring for at least 3 minutes following a system restart.’ In a clinical environment, central monitoring stations are relied upon to give nursing staff a continuous, real-time view of multiple patients’ cardiac rhythms, oxygen levels, and other vital signs simultaneously. Any gap in that data stream, even a brief one, could delay a care team’s awareness of a patient’s deteriorating condition.

What Products Are Being Recalled?

The recall covers the CARESCAPE Central Station under two model or catalogue numbers: 5867474-04 and 5867474-03. Health Canada’s notice lists the affected lot or serial numbers only as exceeding ten units, directing healthcare facilities to contact the manufacturer directly for the specific serial number list rather than publishing it publicly. The product falls under Health Canada’s cardiovascular medical device category.

What Went Wrong?

The issue centers on a software-level performance defect. When a CARESCAPE Central Station running the v3.0.x software is restarted, whether due to a scheduled maintenance reboot, a power interruption, or a system error, the unit does not immediately resume displaying and tracking patient monitoring data. Health Canada’s summary confirms the interruption can last a minimum of three minutes, a window during which bedside alarms and centralized alerts tied to the station may not function as intended.

Health Canada classified the event as a Type II recall, a designation generally reserved for issues that could cause temporary or medically reversible health consequences, or where the probability of serious harm is considered remote. The notice does not indicate that any adverse patient events have been linked to the defect to date.

Who Is Affected?

This recall is directed at healthcare institutions and clinical staff rather than individual consumers. The manufacturer, based in Waukesha, Wisconsin, distributes the CARESCAPE Central Station to hospitals and healthcare networks, and Health Canada has flagged the audience for this alert as ‘Healthcare.’ Facilities in Canada currently operating CSCS v3.0.x units under either listed model number should treat this notice as applicable to their equipment.

What Should You Do?

Health Canada’s guidance for this recall is direct: facilities and biomedical staff should contact the manufacturer if they require additional information about their specific units, including confirmation of affected serial numbers, software mitigation steps, or update timelines. As with other Type II device recalls, hospitals are typically expected to review their internal risk protocols for the interim period, ensuring alternative monitoring safeguards are in place at bedside during any restart of an affected station, until a corrective update or replacement guidance is issued by GE Healthcare.

• Product: CARESCAPE Central Station
• Model or catalogue numbers: 5867474-04 and 5867474-03
• Recall class: Type II
• Recall date: 2026-08-14
• Identification number: RA-82531

Official Statement

In its notice, Health Canada states plainly: ‘GE Healthcare has become aware that the CARESCAPE Central Station (CSCS) v3.0.x may not resume patient monitoring for at least 3 minutes following a system restart.’ The agency’s published action for this alert is limited to advising affected parties to reach out to the manufacturer for further details, and it has not indicated any additional public-facing remedy such as a field correction schedule at this time.

Health Canada continues to monitor medical device recalls through its national alert and recall database and encourages healthcare providers to subscribe to update notifications for ongoing developments related to this and similar device alerts.